No Data
No Data
Barclays Adjusts Price Target on Agilent Technologies to $145 From $135
$1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today
Australia & New Zealand Research Antibodies Market Report 2024-2030, With Leading Players Abcam, BD, Merck, Lonza, Cell Signaling Technology, F. Hoffmann-La Roche, Agilent Technologies, Revvity & More
Citi Maintains Agilent Technologies(A.US) With Buy Rating, Maintains Target Price $165
Single-cell Technologies Research Report 2023-2024 & 2029 10x Genomics, Agilent Technologies, BD, Bio-Rad Laboratories, Danaher, Illumina, Merck, Promega, Qiagen, & Thermo Fisher Scientific - ResearchAndMarkets.com
Do Options Traders Know Something About Agilent Technologies (A) Stock We Don't?
No Data
No Data
BLACKLIST00 : On stock
Credible Commerce : Nicely done I’m still working lol